Li K - Search Results

1

CD31-labeled circulating endothelial cells as predictor in anlotinib-treated non-small-cell lung cancer: Analysis on ALTER-0303 study.

Liu Z, Wang J, Meng Z, Wang X, Zhang C, Qin T, Chen J, Jiang X, Wang L, Lin L, Zhang X, Chen P, Huang C, Jiang R, Li K. Liu Z, et al. Among authors: li k. Cancer Med. 2018 Jul;7(7):3011-3021. doi: 10.1002/cam4.1584. Epub 2018 Jun 1. Cancer Med. 2018. PMID: 29856135 Free PMC article.

2

[Circulating endothelial cells in the peripheral blood of advanced NSCLC patients].

Huang C, Li K, Wei XY, Niu RF, Sun Y, Wang JW, Zhu YZ, Xu LY, Liu XQ, Gao HJ, Zhou JM, Wang XW. Huang C, et al. Among authors: li k. Zhonghua Zhong Liu Za Zhi. 2006 Oct;28(10):780-3. Zhonghua Zhong Liu Za Zhi. 2006. PMID: 17366796 Clinical Trial. Chinese.

3

[Biological effect of endostatin on transplanted human lung adenocarcinoma Calu-6 tumor in nude mice].

Wang J, Huang C, Wei XY, Zhan ZL, Sun H, Yang Y, Li K. Wang J, et al. Among authors: li k. Zhonghua Zhong Liu Za Zhi. 2008 Apr;30(4):266-9. Zhonghua Zhong Liu Za Zhi. 2008. PMID: 18788629 Chinese.

4

Changes of activated circulating endothelial cells and survivin in patients with non-small cell lung cancer after antiangiogenesis therapy.

Wang J, Huang C, Wei XY, Qi DL, Gong LQ, Mu HY, Yao Q, Li K. Wang J, et al. Among authors: li k. Chin Med J (Engl). 2008 Nov 20;121(22):2234-40. Chin Med J (Engl). 2008. PMID: 19080323 Clinical Trial.

5

[Analysis of cavitation of advanced NSCLC treated by rh-endostatin combined with NP chemotherapy].

Huang C, Wang LC, Xiao JY, Ye ZX, Liu ZJ, Xu WJ, Cheng X, Wang J, Li K. Huang C, et al. Among authors: li k. Zhonghua Zhong Liu Za Zhi. 2008 Sep;30(9):712-5. Zhonghua Zhong Liu Za Zhi. 2008. PMID: 19173919 Clinical Trial. Chinese.

6

[Observation of the antitumor effect of endostar combined with docetaxel under different administration sequences].

Yuan J, Wu CW, Liu ZJ, Wei XY, Li K. Yuan J, et al. Among authors: li k. Zhonghua Zhong Liu Za Zhi. 2010 Aug;32(8):580-5. Zhonghua Zhong Liu Za Zhi. 2010. PMID: 21122408 Chinese.

7

A phase I pharmacokinetics study of 9-nitrocamptothecin in patients with advanced solid tumors.

Yan Z, Zhu Z, Li K, Chen P, Wang L, Huang C, Xue J, Liu M. Yan Z, et al. Among authors: li k. Cancer Chemother Pharmacol. 2011 Apr;67(4):955-61. doi: 10.1007/s00280-010-1546-z. Epub 2010 Dec 30. Cancer Chemother Pharmacol. 2011. PMID: 21191594 Clinical Trial.

8

[Clinical characteristics and prognosis of large cell lung cancer].

Chen C, Chen P, Zhang CC, Li N, Jin ZL, Li K. Chen C, et al. Among authors: li n, li k. Zhonghua Zhong Liu Za Zhi. 2010 Dec;32(12):932-4. Zhonghua Zhong Liu Za Zhi. 2010. PMID: 21223803 Chinese.

9

Correlation of genes associated with drug response to prognosis of large cell lung carcinoma.

Chen C, Jiang XL, Zhang CC, Li K. Chen C, et al. Among authors: li k. Chin J Cancer. 2011 Jul;30(7):497-504. doi: 10.5732/cjc.010.10503. Chin J Cancer. 2011. PMID: 21718596 Free PMC article.

10

[Comparison of the effect of rh-endostatin on intratumoral and myocardial micrangium in mice].

Zhang CC, Li K, Wei XY, Chen C, Yuan J, Wang J. Zhang CC, et al. Among authors: li k. Zhonghua Zhong Liu Za Zhi. 2011 Jun;33(6):415-20. Zhonghua Zhong Liu Za Zhi. 2011. PMID: 21875480 Chinese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

27,787 results

Search Page

Filters